Patients with interleukin-2-inducible T-cell kinase (ITK) deficiency is prone to lymphoproliferative diseases, including Hodgkin and non-Hodgkin lymphoma, EBV lymphoproliferative disease, and hemophagocytic lymphohistiocytosis [30]. This evidence concerns the gene ITK and non-Hodgkin lymphoma.